Wenemea ApS
Private limited companyCVR 43754793Aarhus CActive
Wenemea ApS is a private limited company, based in Aarhus C, active in research and experimental development on natural sciences and engineering, founded in 2023. After a loss in 2024, the company made a profit of DKK 32,605 in 2025. Equity grew to DKK 51,470 in 2025. 5 other companies in the database are registered at the same address.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Gross profit rose 173% (2024 → 2025), to DKK 790k.
- Net profit went from a loss of DKK 1,201 to a profit of DKK 32,605 (2024 → 2025).
- Equity rose 173% (2024 → 2025), to DKK 51,470.
Management and owners, last 24 months
- New in management: Poul Sohl (chair of the board, 27/10/2025).
- Stepped down: Teit Weirum Knudsen (chair of the board, 26/10/2025), Ralf Sohl (board member, 26/10/2025) and Poul Sohl (board member, 26/10/2025).
- New owners registered: Michael Pedersen (07/04/2026), Martin Nors Skov (07/04/2026) and Christian Nielsens Fond (07/04/2026) (+4).
- No longer registered as owner: Michael Pedersen (15/02/2026), Martin Nors Skov (15/02/2026) and Christian Nielsens Fond (15/02/2026) (+3).
Registrations, last 24 months
- 22/09/2026: Moved to Universitetsbyen 76, 8000 Aarhus C
- 07/04/2026: Share capital changed from 44,000 DKK to 48,713 DKK
- 16/02/2026: Share capital changed from 40,000 DKK to 44,000 DKK
- 13/03/2025: Moved to Peter Sabroes Gade 7, 8000 Aarhus C
- 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2023–2025 · amounts in DKK thousandEquity and net profit
| 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | – |
| Gross profit | 287 | 290 | 790 | +172.6% |
| Operating profit (EBIT) | −19 | −1 | 33 | +2,814.8% |
| Profit before tax | −20 | −1 | 33 | +2,814.8% |
| Net profit | −20 | −1 | 33 | +2,814.8% |
| Total assets | 67 | 419 | 442 | +5.4% |
| Equity | 20 | 19 | 51 | +172.8% |
| Liabilities | 47 | 400 | 390 | −2.5% |
| Cash and cash equivalents | 52 | 343 | 394 | +15.1% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Annual reports
3 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 09/01/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 18/06/2025 | The company | PDF not statedXBRL |
| 2023 | 05/01/2023 – 31/12/2023 | 10/06/2024 | The company | PDF not statedXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 48,730of 69,742 Better than 30% | No. 57,305of 69,964 Better than 18% |
| Same industry and fewer than 20 employees329 companies in the comparison | No. 128of 323 Better than 61% | No. 211of 329 Better than 36% |
| Companies that are founded within the last five years16,662 companies in the comparison | No. 10,288of 16,614 Better than 38% | No. 11,401of 16,661 Better than 32% |
| All companies of type ApS66,508 companies in the comparison | No. 46,906of 66,379 Better than 29% | No. 53,550of 66,505 Better than 19% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- Wenemea ApSDKK 790k
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Wenemea ApSDKK 32,605
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- Wenemea ApSDKK 51,470
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- Wenemea ApS2
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Basecamp invest ApS10%
- Poul Sohl10%
- Michael Pedersen20%
- Martin Nors Skov25%
- Christian Nielsens Fond10%
- EP Capital A/S5%
Management
5 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Poul Sohl | CEO | 05/01/2023 |
| Martin Nors Skov | Director | 05/01/2023 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Michael Pedersen | Board member | 05/01/2023 |
| Martin Nors Skov | Board member | 05/01/2023 |
| Poul Sohl | Chair of the board | 27/10/2025 |
- Founders
- Michael Pedersen, Martin Nors Skov, Basecamp invest ApS
Former management (3)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Teit Weirum Knudsen | Chair of the board | 05/01/2023 | 26/10/2025 |
| Ralf Sohl | Board member | 05/01/2023 | 26/10/2025 |
| Poul Sohl | Board member | 05/01/2023 | 26/10/2025 |
Signing rule: Selskabet tegnes af to direktører i forening eller af den samlede bestyrelse.
Address and production units
1 active production unitsUniversitetsbyen 76
8000 Aarhus C
Aarhus Municipality · Postcode 8000
Other companies at the address (5)
- MultiBiopsy ApSManufacture of medical and dental instruments and supplies
- Heart2Heart ApSIT infrastructure, data processing, hosting and related activities
- Capnova A/SOther financial service activities n.e.c.
- Endogen ApSResearch and experimental development on natural sciences and engineering
- EntoPrime ApSResearch and experimental development on natural sciences and engineering
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Wenemea ApS | Universitetsbyen 76, 8000 Aarhus C | 2 | 1028897002 |
Purpose
Selskabets formål er udvikling af metoder inden for neurologiske målinger, samt enhver i forbindelse hermed stående virksomhed.
The purpose is quoted from the register in Danish.
Changes year by year
38 registered events202617 changesaddress 1 · capital 2 · ownership 13 · accounts 1
- AddressMoved to Universitetsbyen 76, 8000 Aarhus C
- CapitalShare capital changed from 44,000 DKK to 48,713 DKK
- OwnershipMartin Nors Skov registered as owner (25%)
- OwnershipCHRISTIAN NIELSENS FOND registered as owner (10%)
- OwnershipEP Capital A/S registered as owner (5%)
- OwnershipMichael Pedersen registered as owner (20%)
- OwnershipMartin Nors Skov is no longer registered as owner
- OwnershipCHRISTIAN NIELSENS FOND is no longer registered as owner
- OwnershipMichael Pedersen is no longer registered as owner
- CapitalShare capital changed from 40,000 DKK to 44,000 DKK
- OwnershipMartin Nors Skov registered as owner (33.33%)
- OwnershipCHRISTIAN NIELSENS FOND registered as owner (5%)
- OwnershipMichael Pedersen registered as owner (25%)
- OwnershipCHRISTIAN NIELSENS FOND is no longer registered as owner
- OwnershipMartin Nors Skov is no longer registered as owner
- OwnershipMichael Pedersen is no longer registered as owner
- AccountsAnnual report for 2025 published
20257 changesmanagement 4 · accounts 1 · address 1 · industry 1
- ManagementPoul Sohl appointed chair of the board
- ManagementRalf Sohl stepped down as board member
- ManagementPoul Sohl stepped down as board member
- ManagementTeit Weirum Knudsen stepped down as chair of the board
- AccountsAnnual report for 2024 published
- AddressMoved to Peter Sabroes Gade 7, 8000 Aarhus C
- IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)
20243 changesownership 2 · accounts 1
- OwnershipPoul Sohl registered as owner (10%)
- OwnershipCHRISTIAN NIELSENS FOND registered as owner (5%)
- AccountsAnnual report for 2023 published
202311 changesfounded 1 · management 7 · ownership 3
- FoundedRegistered as Wenemea ApS
- ManagementRalf Sohl appointed board member
- ManagementPoul Sohl appointed board member
- ManagementMichael Pedersen appointed board member
- ManagementTeit Weirum Knudsen appointed chair of the board
- ManagementMartin Nors Skov appointed director
- ManagementMartin Nors Skov appointed board member
- ManagementPoul Sohl appointed ceo
- OwnershipBasecamp invest ApS registered as owner (10%)
- OwnershipMartin Nors Skov registered as owner (33.33%)
- OwnershipMichael Pedersen registered as owner (25%)
Related companies
Same industry in Aarhus
- Vestas Wind Systems A/S3,108 employees
- SEGES Innovation P/S520 employees
- Alx A/S109 employees
- NMD Pharma A/S64 employees
- Innovationscenter for Økologisk Landbrug P/S52 employees
- Cercare Medical A/S28 employees
Same people in management
- Prooffice Gruppen ApSvia Poul Sohl
- Umwelt ApSvia Ralf Sohl
- Danline Innovation A/Svia Poul Sohl
- Gneis ApSvia Teit Weirum Knudsen
- Steep & Deep Online ApSvia Poul Sohl
- Åbn ApSvia Poul Sohl
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.